Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects

Obesity

Volumn 23, Issue 2, 2015, Pages 286-289

  Oliveira, Adriana L ^a   Azevedo, Debora C ^a   Bredella, Miriam A ^a   Stanley, Takara L ^a   Torriani, Martin ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL CIRCUMFERENCE; ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSITY; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRA-ABDOMINAL FAT; LIPIDS; MALE; MIDDLE AGED; OBESITY; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; RISK FACTORS; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84922705888     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20957     Document Type: Article

References (20)

1. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
2. Sims EAH,. Are there persons who are obese, but metabolically healthy? Metabolism 2001; 50: 1499-1504.
3. Kuk JL, Ardern CI,. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009; 32: 2297-2299.
4. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215.
5. Hamer M, Stamatakis E,. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
6. Hinnouho G-M, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A,. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabet Care 2013; 36: 2294-2300.
7. Hinnouho G-M, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2014. doi: 10.1093/eurheartj/ehu123. [Epub ahead of print].
8. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
9. Christen T, Sheikine Y, Rocha VZ, et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging 2010; 3: 843-851.
10. Virtanen KA, Lonnroth P, Parkkola R, et al. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 2002; 87: 3902-3910.
11. Expert panel on detection E and T of HBC in A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA J Am Med Assoc 2001; 285: 2486-2497.
12. Shah NR, Braverman ER,. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin., Nizami Q, (ed.). PLoS One 2012; 7: e33308.
13. Gealekman O, Guseva N, Hartigan C, et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011; 123: 186-194.
14. Farb MG, Ganley-Leal L, Mott M, et al. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol 2012; 32: 467-473.
15. Büsing KA, Schönberg SO, Brade J, Wasser K,. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT. Nucl Med Biol 2013; 40: 206-213.
16. Camhi SM, Katzmarzyk PT,. Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int J Obes (Lond) 2013; 38: 1142-1145.
17. Koster A, Stenholm S, Alley DE, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010; 18: 2354-2361.
18. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
19. Heianza Y, Arase Y, Tsuji H, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: toranomon hospital health management center study 20 (TOPICS 20). J Clin Endocrinol Metab 2014; 99: 2952-2960.
20. Aung K, Lorenzo C, Hinojosa MA, Haffner SM,. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab 2014; 99: 462-468.